KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Gross Profit (2016 - 2025)

LifeMD's Gross Profit history spans 14 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 316.54% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $54.5 million, down 58.75%, while the annual FY2025 figure was $166.3 million, 24.71% up from the prior year.
  • Gross Profit reached $2.8 million in Q4 2025 per LFMD's latest filing, down from $52.8 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $52.8 million in Q3 2025 to a low of -$1.6 million in Q1 2025.
  • Average Gross Profit over 5 years is $24.8 million, with a median of $24.9 million recorded in 2022.
  • Peak YoY movement for Gross Profit: soared 405.1% in 2021, then plummeted 103.97% in 2025.
  • A 5-year view of Gross Profit shows it stood at $21.8 million in 2021, then rose by 10.08% to $24.1 million in 2022, then skyrocketed by 64.25% to $39.5 million in 2023, then crashed by 103.33% to -$1.3 million in 2024, then soared by 316.54% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Gross Profit are $2.8 million (Q4 2025), $52.8 million (Q3 2025), and $455210.0 (Q2 2025).